Stage 2 Meaningful Use: Tackling the Encryption Conundrum

Editorial Staff | | Health Exec | Policy & Regulations

March 4, 2013, 9:45 AM - 10:45 AM | The Centers for Medicare & Medicaid Services (CMS) has specifically called out the use of encryption for Stage 2 Meaningful use. How best should providers do this? Understand the pitfalls and challenges involved.

Speaker(s):
  • Feisal Nanji, CISSP
 Objectives:
  • Describe the challenges of using encryption for all data at rest
  • identify the strategies available for encrypting data without overwhelming an organization
  • Demonstrate how to achieve encryption effectively and at reasonable cost

 

 

Editorial Staff

Related Content

Report: Elon Musk stepping down from DOGE in ‘coming weeks’
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
HHS ‘dramatic restructuring’ begins as employees turned away by security
California ballot measure named after Luigi Mangione lands on AG’s desk
FDA announces new recall of Medtronic surgical devices over safety concerns
300+ groups urge Senate GOP to reject Medicaid cuts

Around the web

Cardiovascular Business
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

Radiology Business
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

One product is being pulled from the market, and the other is receiving updated instructions for use.

AI in Healthcare
What federal regulators can learn from the states about AI oversight

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?